The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
BH3-only proteins in apoptosis at a glance
Open accessAbstract
Apoptosis is a genetically programmed process for the elimination of damaged or redundant cells by activation of caspases (aspartate-specific cysteine proteases). Caspases cleave vital proteins, leading the cell to fragment into vesicles that are rapidly engulfed by phagocytes (for reviews, see Hotchkiss et al., 2009; Strasser et al., 2011). Defects in apoptosis contribute to many diseases, ranging from cancer and autoimmunity to degenerative disorders. This Poster focuses on key initiators of apoptosis: the BH3-only proteins. CertainBH3-onlyproteinshave also been implicated in non-apoptotic processes (see Elgendy et al., 2011; Yeretssian et al., 2011).In mammalian cells, there are two pathways to apoptosis (Hotchkiss et al., 2009; Strasser et al., 2011) (see Poster): the ‘extrinsic’ pathway, which is triggered by engagement of cell surface ‘death receptors’ of the tumour necrosis factor receptor family with their ligands, and the ‘intrinsic’ (or mitochondrial) pathway, which is triggered by diverse cellular stresses, such as cytokine deprivation, DNA damage or oncogene activation. These pathways are largely independent (Strasser et al., 1995), each activating different initiator caspases, but they converge at the level of effector caspases.The intrinsic pathway is controlled by interactions between proteins related to BCL2, the oncoprotein activated by chromosome translocation in follicular lymphoma (Tsujimoto et al., 1985). BCL2 inhibits apoptosis (Vaux et al., 1988), as do four close homologues – BCL-XL, BCL-W, MCL1 and A1 – which share four BCL2 homology (BH) domains (see Poster). Other relatives that are similar in sequence and structure – BAX, BAK (and possibly BOK) – instead promote apoptosis, as do distant relatives (BIM, PUMA, NOXA, BID, BMF, BAD, BIK and HRK), which have only the BH3 domain in common with BCL2 or each other. Induction of apoptosis requires the activation of members of both of these death-promoting families (Cheng et al., 2001; Zong et al., 2001). Exposure to stress results in the induction of BH3-only proteins, which neutralise the pro-survival proteins. Subsequent activation of BAX and BAK, which involves their conformational change and homo-oligomerisation on the mitochondrial outer membrane, leads to its permeabilisation. The consequent release of cytochrome c into the cytoplasm promotes the formation of the apoptosome complex, which activates initiator caspase-9.The ∼26-residue BH3 domain is an amphipathic α-helix that binds with high affinity to a hydrophobic groove on the surface of pro-survival BCL2 family members (Sattler et al., 1997). Individual BH3-only proteins have varying affinities for different pro-survival proteins (Opferman et al., 2003; Chen et al., 2005; Kuwana et al., 2005; Certo et al., 2006; Ku et al., 2011). Whereas BIM, tBID (the cleaved active form of BID; see below) and PUMA bind with high affinity to all pro-survival proteins, others are more selective; for example, BAD binds with high affinity only to BCL2, BCL-XL and BCL-W, and NOXA only to MCL1 and A1. Importantly, the ‘promiscuous’ binders are more potent killers than the more selective binders, but co-expression of ‘selective binders’ that have complementary specificity (e.g. BAD plus NOXA), kills cells as potently as the ‘promiscuous’ BIM (Chen et al., 2005). This suggests that efficient apoptosis requires neutralisation of all pro-survival BCL2 family members expressed within a given cell.However, there is still vigorous debate on how the BH3-only proteins trigger activation of BAX and BAK (Chipuk et al., 2010; Strasser et al., 2011). The ‘direct activation’ model (Letai et al., 2002; Kuwana et al., 2005; Chipuk et al., 2010) (see Poster) proposes that certain BH3-only proteins termed ‘activators’ – for example BIM, tBID and perhaps PUMA (Cartron et al., 2004) – bind transiently with low affinity to BAX and BAK (‘hit and run’), thereby triggering their conformational change and subsequent oligomerisation on the mitochondrial outer membrane. According to this model, the other BH3-only proteins, termed ‘sensitisers’ (for example, BAD, BIK, HRK), bind only to pro-survival BCL2 family members, but in doing so they liberate any complexed ‘activator’ BH3-only proteins to activate BAX or BAK. Recently, the distinction between ‘activator’ and ‘sensitiser’ BH3-only proteins has become more blurred, with claims that NOXA (Dai et al., 2011) and BMF (Du et al., 2011) can act as direct activators.The ‘indirect activation’ model (see Poster) posits that the primary role of all BH3-only proteins is to bind to pro-survival BCL2 family members, thereby preventing them from binding to and neutralising any activated BAX or BAK molecules (Chen et al., 2005; Willis et al., 2005; Willis et al., 2007; Uren et al., 2007). This model envisages that activation of a BAX or BAK protein is the result of a conformational change that exposes its BH3 domain, which, if not bound by a pro-survival BCL2-like protein, would catalys
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Self-citationKuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
Programmed Anuclear Cell Death Delimits Platelet Life Span
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.037 · Cited by 1,031 · cited 11×
“According to this model, the other BH3only proteins, termed ‘sensitisers’ (for example, BAD, BIK, HRK), bind only to pro-survival BCL2 family members, but in doing so they liberate any complexed ‘activator’ BH3-only proteins to activate BAX or BAK.”
BackgroundInfluentialBid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
Yin, X.-M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K. A., & Korsmeyer, S. J. (1999) · Nature · doi:10.1038/23730 · Cited by 1,004
Wilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70261-8 · Cited by 876 · cited 1×
“ABT-263, currently in early Phase I–II clinical trials, has shown promising efficacy in chronic lymphocytic leukaemia (CLL) patients (Gandhi et al., 2011; Tse et al., 2008; Wilson et al., 2010).”
BackgroundBH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes
Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L.-C., Coultas, L., Puthalakath, H., Pellegrini, M., Cory, S., Adams, J. M., & Strasser, A. (2002) · Nature · doi:10.1038/415922a · Cited by 782
Self-citationPuthalakath, H., Villunger, A., O'Reilly, L. A., Beaumont, J. G., Coultas, L., Cheney, R. E., Huang, D. C. S., & Strasser, A. (2001) · Science · doi:10.1126/science.1062257 · Cited by 656
Self-citation
Cited by
Activation of apoptosis signalling pathways by reactive oxygen species
Redza-Dutordoir, M., & Averill-Bates, D. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.012 · Cited by 3,731
Lysosomal cell death at a glance
Aits, S., & Jäättelä, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.091181 · Cited by 667
The BCL-2 arbiters of apoptosis and their growing role as cancer targets
Adams, J. M., & Cory, S. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.161 · Cited by 530
Self-citationThe BCL-2 protein family, BH3-mimetics and cancer therapy
Delbridge, A. R. D., & Strasser, A. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.50 · Cited by 531
Self-citationThe BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
Vogler, M., Braun, Y., Smith, V. M., Westhoff, M.-A., Pereira, R. S., Pieper, N. M., Anders, M., Callens, M., Vervliet, T., Abbas, M., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02176-0 · Cited by 462
Metadata
- Authors
- Happo, L., Strasser, A., & Cory, S.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2012-03-01
- Volume
- 125
- Issue
- 5
- Pages
- 1081-1087
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2067570858
- Cited by
- 193
- References
- 17
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BH3-only proteins in apoptosis at a glance. https://app.cochat.ai/papers/10.1242/jcs.090514
- The paper
- Happo, L., Strasser, A., & Cory, S. (2012). BH3-only proteins in apoptosis at a glance. Journal of Cell Science. https://doi.org/10.1242/jcs.090514
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.